<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>佰傲谷BioValley | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-26T13:25:55+08:00</updated>
  <subtitle>佰傲谷致力于打造一个垂直于生物制品领域的第三方平台。为生物制药企业提供品牌推广、技术咨询、项目交易、企业合作、人才培养等服务。为生物制药行业从业人员提供沟通交流、会议培训、工作求职、个人展示平台</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2020 Think Big 十佳入选项目专访 | 致谨生物：小分子或引领下一代肿瘤免疫疗法</title>
    <updated>2020-12-26T11:14:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/VpK8HJQ5l27nd6AuzPbNjQ</id>
    <link href="https://mp.weixin.qq.com/s/VpK8HJQ5l27nd6AuzPbNjQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>建立群体免疫，需要多少人接种新冠疫苗？</title>
    <updated>2020-12-26T11:14:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/G_FcRZxaU8RNVzwq0TIzBA</id>
    <link href="https://mp.weixin.qq.com/s/G_FcRZxaU8RNVzwq0TIzBA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正式启动！2021年不可多得的细胞基因免疫治疗技术专场盛会有哪些精彩看点？</title>
    <updated>2020-12-26T11:14:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-26:/s/LeOhqAOxiV9GDGOJq-sorg</id>
    <link href="https://mp.weixin.qq.com/s/LeOhqAOxiV9GDGOJq-sorg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>极目生物获得国内首个治疗UME临床试验批件! 脉络膜上腔给药注射给患者带来更多福音</title>
    <updated>2020-12-25T12:05:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/xhL_6EXGzb_xRSsV-3tsPA</id>
    <link href="https://mp.weixin.qq.com/s/xhL_6EXGzb_xRSsV-3tsPA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>212.5万美元天价药上市第二年就卖成重磅炸弹，四成收益却贡献给了病毒载体</title>
    <updated>2020-12-25T12:05:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/9Yj4EsTMj1GtORwBIZeTyQ</id>
    <link href="https://mp.weixin.qq.com/s/9Yj4EsTMj1GtORwBIZeTyQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>默克收购A2的T细胞治疗平台，共同开发实体瘤同种异体细胞疗法</title>
    <updated>2020-12-25T12:05:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/kicAB7vYh5CfWjO0NSKpoA</id>
    <link href="https://mp.weixin.qq.com/s/kicAB7vYh5CfWjO0NSKpoA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>佰傲谷发布 | 复宏汉霖CFO辞任，李鑫磊接任</title>
    <updated>2020-12-25T12:05:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-25:/s/SFOFLZ4sYMJ0xCXGdsQ-Mg</id>
    <link href="https://mp.weixin.qq.com/s/SFOFLZ4sYMJ0xCXGdsQ-Mg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国药中生新冠病毒灭活疫苗（Vero）上市申请获得NMPA受理</title>
    <updated>2020-12-24T12:22:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/voV7AA0EAtmgwshTye1PKA</id>
    <link href="https://mp.weixin.qq.com/s/voV7AA0EAtmgwshTye1PKA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>双旦礼遇，新年钜献！佰傲谷2021年TG-Bio第二届免疫治疗技术大会报名正式开启！</title>
    <updated>2020-12-24T12:22:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/kqFbbLynkTJRX92e0JBx5A</id>
    <link href="https://mp.weixin.qq.com/s/kqFbbLynkTJRX92e0JBx5A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药明生物1.83亿美元收购拜耳工厂，国内CDMO或将突围，迎来黄金时代</title>
    <updated>2020-12-24T12:22:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/zxr-_ZpBGgSAqOUBK_3Hpw</id>
    <link href="https://mp.weixin.qq.com/s/zxr-_ZpBGgSAqOUBK_3Hpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球首个KRAS靶点药物Sotorasib向EMA提交上市许可申请</title>
    <updated>2020-12-23T16:41:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/aV5b04u_TAsyHkFyEeHCfQ</id>
    <link href="https://mp.weixin.qq.com/s/aV5b04u_TAsyHkFyEeHCfQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药械审大湾区分中心成立！与昨天成立的长三角分中心有这些不同</title>
    <updated>2020-12-23T16:41:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/QKExlzy_hLnQ7diSQnNbMw</id>
    <link href="https://mp.weixin.qq.com/s/QKExlzy_hLnQ7diSQnNbMw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BV Release | 维立志博LBL-003注射液获美国FDA临床试验许可</title>
    <updated>2020-12-23T16:41:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-23:/s/4hkOkzBoN8-HIDepMQL19w</id>
    <link href="https://mp.weixin.qq.com/s/4hkOkzBoN8-HIDepMQL19w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>变数横生：uniQure血友病基因疗法临床Ⅲ期遭FDA搁置</title>
    <updated>2020-12-22T12:39:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/-PRfwy2IVg4NfnCtJ-qYJg</id>
    <link href="https://mp.weixin.qq.com/s/-PRfwy2IVg4NfnCtJ-qYJg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>权威学术期刊主编如何看待新冠疫苗？</title>
    <updated>2020-12-22T12:39:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/SgV7-QqaVohUe932Ul8lUQ</id>
    <link href="https://mp.weixin.qq.com/s/SgV7-QqaVohUe932Ul8lUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>佰傲谷发布 | 规范疫苗批签发管理， 《生物制品批签发管理办法》2021年3月1日起实施</title>
    <updated>2020-12-22T12:39:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/EuDO0cI2cveZWAgg5jueEA</id>
    <link href="https://mp.weixin.qq.com/s/EuDO0cI2cveZWAgg5jueEA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>生物工艺江湖的生存之道：固守还是破局？</title>
    <updated>2020-12-21T13:06:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/caBAzRg4POz6dsM-k8XOoA</id>
    <link href="https://mp.weixin.qq.com/s/caBAzRg4POz6dsM-k8XOoA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>GSK布局IBD新疗法，成功入选Sosei的global licensing名单</title>
    <updated>2020-12-21T13:06:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/qavo3EGaX56blMTmkLaL2g</id>
    <link href="https://mp.weixin.qq.com/s/qavo3EGaX56blMTmkLaL2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>降低复发风险80%！谁说EGFR治疗NSCLC的TMB不高？FDA批准阿斯利康辅助疗法</title>
    <updated>2020-12-21T13:06:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/7k9GIF-G40xknDX7X-lXKA</id>
    <link href="https://mp.weixin.qq.com/s/7k9GIF-G40xknDX7X-lXKA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>使用先进的生物工艺数据管理平台提升R&amp;D阶段的质量和效率！</title>
    <updated>2020-12-21T13:06:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/Mx8nO39kK8_jVOuyfZG2MQ</id>
    <link href="https://mp.weixin.qq.com/s/Mx8nO39kK8_jVOuyfZG2MQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>